Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.

Nassiri M, Liu J, Kulak S, Uwiera RR, Aird WC, Ballermann BJ, Jahroudi N.

Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1423-9. doi: 10.1161/ATVBAHA.110.206680. Epub 2010 Apr 29.

2.

Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice.

Kleinschmidt AM, Nassiri M, Stitt MS, Wasserloos K, Watkins SC, Pitt BR, Jahroudi N.

J Biol Chem. 2008 Feb 1;283(5):2741-50. Epub 2007 Nov 28.

3.

Hypoxia results in upregulation and de novo activation of von Willebrand factor expression in lung endothelial cells.

Mojiri A, Nakhaii-Nejad M, Phan WL, Kulak S, Radziwon-Balicka A, Jurasz P, Michelakis E, Jahroudi N.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1329-38. doi: 10.1161/ATVBAHA.113.301359. Epub 2013 Apr 11. Erratum in: Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):e123.

5.

An NF1-like protein functions as a repressor of the von Willebrand factor promoter.

Jahroudi N, Ardekani AM, Greenberger JS.

J Biol Chem. 1996 Aug 30;271(35):21413-21.

6.

Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter.

Wang X, Peng Y, Ma Y, Jahroudi N.

Blood. 2004 Sep 15;104(6):1725-32. Epub 2004 May 18.

8.

Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle.

Liu J, Yuan L, Molema G, Regan E, Janes L, Beeler D, Spokes KC, Okada Y, Minami T, Oettgen P, Aird WC.

Blood. 2011 Jan 6;117(1):342-51. doi: 10.1182/blood-2010-06-287987. Epub 2010 Oct 27.

9.

Endothelial-cell-specific regulation of von Willebrand factor gene expression.

Jahroudi N, Lynch DC.

Mol Cell Biol. 1994 Feb;14(2):999-1008.

10.

Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.

Zhou D, Masri S, Ye JJ, Chen S.

Gene. 2005 Nov 21;361:89-100. Epub 2005 Sep 21.

PMID:
16181749
11.

Two repressor elements inhibit expression of the von Willebrand factor gene promoter in vitro.

Ardekani AM, Greenberger JS, Jahroudi N.

Thromb Haemost. 1998 Sep;80(3):488-94.

PMID:
9759632
12.

Functional characterization of a 13-bp deletion (c.-1522_-1510del13) in the promoter of the von Willebrand factor gene in type 1 von Willebrand disease.

Othman M, Chirinian Y, Brown C, Notley C, Hickson N, Hampshire D, Buckley S, Waddington S, Parker AL, Baker A, James P, Lillicrap D.

Blood. 2010 Nov 4;116(18):3645-52. doi: 10.1182/blood-2009-12-261131. Epub 2010 Aug 9.

13.

Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor.

Hough C, Cuthbert CD, Notley C, Brown C, Hegadorn C, Berber E, Lillicrap D.

Blood. 2005 Feb 15;105(4):1531-9. Epub 2004 Oct 21.

14.

A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.

Liu J, Kanki Y, Okada Y, Jin E, Yano K, Shih SC, Minami T, Aird WC.

J Thromb Haemost. 2009 Aug;7(8):1384-92. doi: 10.1111/j.1538-7836.2009.03501.x. Epub 2009 May 30.

15.
16.

NFI in the development of the olfactory neuroepithelium and the regulation of olfactory marker protein gene expression.

Behrens M, Venkatraman G, Gronostajski RM, Reed RR, Margolis FL.

Eur J Neurosci. 2000 Apr;12(4):1372-84.

PMID:
10762365
17.

Differential binding of the transcription factors Sp1, AP-1, and NFI to the promoter of the human alpha5 integrin gene dictates its transcriptional activity.

Gingras ME, Masson-Gadais B, Zaniolo K, Leclerc S, Drouin R, Germain L, Guérin SL.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):57-67. doi: 10.1167/iovs.08-2059. Epub 2008 Sep 4.

PMID:
18775869
18.

Characterization of the mouse von Willebrand factor promoter.

Guan J, Guillot PV, Aird WC.

Blood. 1999 Nov 15;94(10):3405-12.

19.

Nuclear factor I transcription factors regulate IGF binding protein 5 gene transcription in human osteoblasts.

Pérez-Casellas LA, Wang X, Howard KD, Rehage MW, Strong DD, Linkhart TA.

Biochim Biophys Acta. 2009 Feb;1789(2):78-87. doi: 10.1016/j.bbagrm.2008.08.013. Epub 2008 Sep 10.

20.

NF1 regulatory element functions as a repressor of tissue plasminogen activator expression.

Pham NL, Franzen A, Levin EG.

Arterioscler Thromb Vasc Biol. 2004 May;24(5):982-7. Epub 2004 Mar 25.

Items per page

Supplemental Content

Write to the Help Desk